Dendreon (Provenge) Initiates Second of Two New Phase 2 Trials

Dendreon Corporation (Nasdaq: DNDN), the company that is testing Provenge a potential vaccine for prostate cancer, has started a second of two new Phase 2 trials. The multicenter trial, called ProACT (PROstate Active Cellular Therapy), is enrolling 120 men with metastatic, androgen independent prostate cancer. The trial protocol calls for all men to receive active [...]

One Blood Test and Four Different Options

In addition to the three cancers, I also have an arthritic condition. My rheumatologist has prescribed certain medications that require regular monitoring for liver damage, so every six weeks I go into the lab to have a complete blood panel along with my PSA. Included in the blood panel are also some kidney screens. One [...]

A Phase II Trial, A New Type Of Vaccine For Prostate Cancer

I have to admit that cancer researchers are becoming very creative. There is a phase II clinical trial getting ready to start at the Wake Forest University Baptist Medical Center which has a new twist. The treatment is based on injecting white blood cells called 'cancer killing' granulocytes from healthy donors into cancer survivors with [...]

Go to Top